These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11897035)

  • 1. Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment.
    Boffito M; Rossati A; Reynolds HE; Hoggard PG; Back DJ; Di Perri G
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):341-2. PubMed ID: 11897035
    [No Abstract]   [Full Text] [Related]  

  • 2. Efavirenz decreases methadone blood concentrations.
    Marzolini C; Troillet N; Telenti A; Baumann P; Decosterd LA; Eap CB
    AIDS; 2000 Jun; 14(9):1291-2. PubMed ID: 10894303
    [No Abstract]   [Full Text] [Related]  

  • 3. Methadone withdrawal symptoms with nevirapine and efavirenz.
    Pinzani V; Faucherre V; Peyriere H; Blayac JP
    Ann Pharmacother; 2000 Mar; 34(3):405-7. PubMed ID: 10917395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nevirapine induces abstinence symptoms in patients on a methadone maintenance program with HIV infection].
    Baño Rodrigo MD; Agujetas Rodríguez M; López García ML; Guillén Llera JL
    Rev Clin Esp; 2000 Jan; 200(1):12-4. PubMed ID: 10721283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment: opiate withdrawal symptoms induced by antiretroviral drugs.
    Eap CB
    Ann Pharmacother; 2000 Sep; 34(9):1077-8. PubMed ID: 10981259
    [No Abstract]   [Full Text] [Related]  

  • 6. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
    Altice FL; Friedland GH; Cooney EL
    AIDS; 1999 May; 13(8):957-62. PubMed ID: 10371177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
    Otero MJ; Fuertes A; Sánchez R; Luna G
    AIDS; 1999 May; 13(8):1004-5. PubMed ID: 10371190
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of abacavir and efavirenz: new antiretroviral drugs to treat HIV-1 infection.
    Wolbach J; Capoccia K
    Nurse Pract; 1999 Jun; 24(6):81-2, 87-90, 92. PubMed ID: 10431297
    [No Abstract]   [Full Text] [Related]  

  • 9. Efavirenz therapy in drug users.
    Clarke SM; Mulcahy FM
    HIV Med; 2000; 1 Suppl 1():15-7. PubMed ID: 11737363
    [No Abstract]   [Full Text] [Related]  

  • 10. Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program.
    Tossonian HK; Raffa JD; Grebely J; Trotter B; Viljoen M; Mead A; Khara M; McLean M; Duncan F; Fraser C; DeVlaming S; Conway B
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):324-7. PubMed ID: 17468668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA issues labeling changes for efavirenz.
    González-Lahoz J
    AIDS Rev; 2004; 6(3):181-2. PubMed ID: 15595435
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in HIV therapy. Effective and simple therapy with efavirenz].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():36-7. PubMed ID: 11373774
    [No Abstract]   [Full Text] [Related]  

  • 13. Manic syndrome associated with efavirenz overdose.
    Blanch J; Corbella B; García F; Parellada E; Gatell JM
    Clin Infect Dis; 2001 Jul; 33(2):270-1. PubMed ID: 11418896
    [No Abstract]   [Full Text] [Related]  

  • 14. A manic episode associated with efavirenz therapy for HIV infection.
    Shah MD; Balderson K
    AIDS; 2003 Jul; 17(11):1713-4. PubMed ID: 12853762
    [No Abstract]   [Full Text] [Related]  

  • 15. Efavirenz-associated severe hyperlipidemia.
    Bonnet F; Bonarek M; De Witte S; Beylot J; Morlat P
    Clin Infect Dis; 2002 Sep; 35(6):776-7. PubMed ID: 12203183
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efavirenz].
    Taéron C
    Rev Infirm; 2005 May; (111):37-8. PubMed ID: 15991644
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin eruption 8 days after a single dose of efavirenz-containing combination therapy.
    Yazaki H; Kikuchi Y; Oka S
    Jpn J Infect Dis; 2001 Dec; 54(6):246-7. PubMed ID: 11862010
    [No Abstract]   [Full Text] [Related]  

  • 18. Photosensitive drug eruption induced by efavirenz in a patient with HIV infection.
    Furue M
    Intern Med; 2004 Jul; 43(7):533. PubMed ID: 15335175
    [No Abstract]   [Full Text] [Related]  

  • 19. Recreational substance use and tolerance of efavirenz in HIV-1 infected patients.
    Faggian F; Lattuada E; Lanzafame M; Antolini D; Concia E; Vento S
    AIDS Care; 2005 Oct; 17(7):908-10. PubMed ID: 16120507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.
    McCance-Katz EF; Rainey PM; Friedland G; Jatlow P
    Clin Infect Dis; 2003 Aug; 37(4):476-82. PubMed ID: 12905130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.